And yes mate - I've been about since Prima myself, also aware of when Marc started.. that chart isn't any prettier.
My point is, as an investment, neither as Prima or IMM.. there has been a negative return. People can bang on all they like about the data is yet to come, in my uneducated opinion, there is enough data for big pharma to make a call or not. It appears they are not.
A CEO and board are responsible for SP performance, pretty simple. Given this company is based on science and quantitative data - the facts are that the company has underperformed under Marc's watch - based on SP performance. anything else is simply an opinion or emotive argument or hopes and prayers.
Given all the "data is coming" hopes, the 1-year decline doesn't exactly support the notion that the market supports the idea we are about to explode - notwithstanding the manipulation.
IMM Price at posting:
27.0¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)